Direct costs related to rheumatoid arthritis: The patient perspective

Annals of the Rheumatic Diseases

Volumn 64, Issue 10, 2005, Pages 1456-1461

  Hulsemann J L ^a   Mittendorf, T ^b   Merkesdal, S ^a   Handelmann, S ^c   Von Der Schulenburg, J M ^b   Zeidler, H ^a   Ruof, J ^a   Zeh, S ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c University of Hannover ^*

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DEVICE; ECONOMIC EVALUATION; GERMANY; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPITAL CHARGE; HUMAN; MEDICAL FEE; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; REVIEW; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COST; COST OF ILLNESS; DRUG COST; ECONOMICS; FEMALE; HEALTH SERVICE; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT TRANSPORT; STATISTICS; UTILIZATION REVIEW;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; COSTS AND COST ANALYSIS; DRUG COSTS; FEMALE; GERMANY; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; TRANSPORTATION OF PATIENTS;

EID: 27744589307     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.031880     Document Type: Review

References (22)

1. Alexander CG, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA 2003;290:953-8.
2. Hwang W, Weller W, Ireys H, Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood) 2001;20:267-78.
3. Langa KM, Fendrick AM, Chernew ME, Kabeto MU, Paisley KL, Hayman JA. Out-of-pocket healthcare expenditures among older Americans with cancer. Value Health 2004;7:186-94.
4. Fautrel B, Guillemin F. Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 2002;14:121-6.
5. Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 2000;39:28-33.
6. Merkesdal S, Ruof J, Mittendorf T, Mau W, Zeidler H. Health economic research in rheumatoid arthritis. Z Rheumatol 2002;61:21-9.
7. Boonen A, van der Heijde D, Landewe R, Guillemin F, Spoorenberg A, Schouten H, et al. Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis 2003;62:741-7.
8. Lapsley HM, March LM, Tribe KL, Cross MJ, Brooks PM. Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis Care Res 2001;45:301-6.
9. Lapsley HM, March LM, Tribe KL, Cross MJ, Courtenay BG, Brooks PM. Living with rheumatoid arthritis: expenditures, health status, and social impact on patients. Ann Rheum Dis 2002;61:818-21.
10. Liang MH, Larson M, Thompson M. Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984;27:522-9.
11. Cooper NJ, Mugford M, Symmons DPM, Barrett EM, Scott DGI. Total costs and predictors of costs in individuals with early inflammatory polyarthritis: a community-based prospective study. Rheumatology 2002;41:767-74.
12. Hülsemann JL, Mattussek S, Hennig H, Stucki G. Das Qualitatsmanagement der Therapie der chronischen Polyarthritis in der rheumatologischen Praxis. Z Arztl Fortbilt Qualitatssich 2003;97:383-90.
13. Uitz E, Fransen J, Langenegger, Stucki G. Clinical quality management in rheumatoid arthritis: putting theory into practice. Swiss clinical management in rheumatoid arthritis. Rheumatology 2000;39:542-9.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Association 1987 revised criteria for the classifications of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Mittendorf T, Merkesdal S, Zeidler H, Graf von der Schulenburg JM, Ruof J. Costs of ambulatory care for RA patients in Germany. Med klin (Munich) 2005;100:255-61.
16. Ruof J, Hulsemann JL, Mittendorf T, Handelmann S, von der Schulenburg JM, Zeidler H, et al. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on objective data sources. Ann Rheum Dis 2003;62:544-50.
17. Ruof J, Hulsemann JL, Mittendorf T, Handelmann S, von der Schulenburg JM, Zeidler H, et al. Patient-reported health care utilization data in rheumatoid arthritis: what level of detail is required? Arthritis Rheum 2004;51:774-81.
18. Merkesdal S, Ruof J, Hulsemann JL, Maetzel A, Schoffski O, Mau W, et al. Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis. J Rheumatol 2001;28:657-61.
19. Brosius G, Brosius F. SPSS base system and professional statistics. Koesel, Kempten: International Thomson Publishing, 1995.
20. Polikowski M, Santos-Eggimann B. How comprehensive are the basic packages of health services? An international comparison of six health insurance systems. J Health Serv Res Policy 2002;7:133-42.
21. Bridvevaux IP. A survey of patients' out-of-pocket payments for complementary and alternative medicine therapies. Complement Ther Med 2004;12:48-50.
22. Lee JA, McKercher PL. Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordability. Clin Ther 2002;24:1003-12.